| 查看: 116 | 回复: 0 | |||
| 当前主题已经存档。 | |||
xrose木虫 (正式写手)
|
[交流]
Rheumatoid arthritis may be becoming milder
|
||
|
SAN FRANCISCO - Drug companies make $2.5 billion a year selling Viagra, Cialis and Levitra to help men enjoy sex. Since more women suffer from sexual dysfunction than men, developing a drug that could double those sales would seem to be a no-brainer. Yet the pharmaceutical industry has failed women miserably — there isn’t a single sexual dysfunction drug on the market that can help them. Pfizer Inc. last year abandoned an eight-year Viagra study involving 3,000 women, conceding that its famous blue pill only works for men. “I hate to say it, but women are much more complex than men,” said Beverly Whipple, the sex researcher who co-wrote “The G-Spot.” Welsing, at Radboud University Nijmegen Medical Center, in the Netherlands, and colleagues investigated disease activity and disability of all newly diagnosed rheumatoid arthritis patients seen in their clinic from 1985 to 2005. A total of 525 subjects were included in the analysis. Patients seem to be seeking treatment earlier in the course of the disease, the authors report in the medical journal Arthritis & Rheumatism, with the duration of their symptoms having decreased from an average of 309 days two decades ago to 212 days in 2005. All components of a disease activity scale (except well-being) improved over the interval studied, the results indicate, both when the patients were first seen and 5 years after their diagnosis. Initial improvement in disease symptoms with treatment was also greater among more recently diagnosed patients, the researchers note, perhaps because the treatment strategy was more aggressive in more recent patients. “In our opinion there can be two reasons for the less severe disease activity at presentation in the more recent subpopulation of our study,” Welsing commented. “First, patients could come to a rheumatologist earlier after the onset of complaints. Further, it could be that patients with less severe complaints were in the past not referred to a rheumatologist and nowadays are referred to a rheumatologist.” “We cannot be certain that these two phenomena fully explain the decrease in disease activity at presentation,” Welsing said. His group is planning to study trends over time in the longer-term outcomes of rheumatoid arthritis. |
回复此楼» 猜你喜欢
MSER送审了还被拒稿
已经有4人回复
-
今年E04面上
已经有21人回复
-
2026年面上项目中了，2A+B, 会评顺利通过
已经有14人回复
-
b口会评
已经有5人回复
-
在职考研
已经有5人回复
-
大龄残疾硕士的一点执念
已经有22人回复
-
生命口会评
已经有4人回复
-
网络举报学术不端成为了男女之间情杀的手段了，真荒唐。。。
已经有3人回复
-
Suzuki偶联中硼酸酯原料掉下的硼酸酯是否可以自身偶联，生成B2Pin2杂质
已经有3人回复
-
刑法学论文投稿求助
已经有5人回复